[Rd 382 in the treatment of optic nerve diseases of toxic, traumatic or inflammatory etiology].
D000818:Animals; D006168:Guinea Pigs; D006801:Humans; D006879:Hydroxocobalamin / Q000627:therapeutic use*; D009896:Optic Atrophy / Q000188:drug therapy; D009901:Optic Nerve Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D009902:Optic Neuritis / Q000188:drug therapy; D011817:Rabbits; D051381:Rats
D006879:Hydroxocobalamin
Apport du Rd 382 dans le traitement des souffrances du nerf optique d'origine toxique, traumatique ou inflammatoire.